Literature DB >> 8280410

Successful treatment of AIDS-related cryptosporidial sclerosing cholangitis.

A A Hamour1, A Bonnington, B Hawthorne, E G Wilkins.   

Abstract

OBJECTIVE: Cryptosporidium is a well recognized cause of AIDS-related sclerosing cholangitis for which no efficacious therapy exists at present. We evaluated the efficiency of the combination of paromomycin and letrazuril in the treatment of this condition. CASE REPORT: We report a case of cryptosporidial cholangitis in a patient with AIDS who responded to treatment with intravenous paromomycin followed by oral letrazuril as maintenance therapy.
CONCLUSION: The combination of paromomycin and letrazuril should be considered in the treatment of AIDS-related sclerosing cholangitis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8280410     DOI: 10.1097/00002030-199311000-00007

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  4 in total

1.  Synergistic anticryptosporidial potential of the combination alpha-1-antitrypsin and paromomycin.

Authors:  J R Forney; S Yang; M C Healey
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

2.  Cryptosporidium parvum-specific CD4 Th1 cells from sensitized donors responding to both fractionated and recombinant antigenic proteins.

Authors:  Maria Angeles Gomez Morales; Raffaella Mele; Alessandra Ludovisi; Fabrizio Bruschi; Fabio Tosini; Rachele Riganò; Edoardo Pozio
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

Review 3.  Atypical p-ANCA in PSC and AIH: a hint toward a "leaky gut"?

Authors:  Birgit Terjung; Ulrich Spengler
Journal:  Clin Rev Allergy Immunol       Date:  2009-02       Impact factor: 8.667

4.  AIDS Cholangiopathy.

Authors:  Tony E. Yusuf; Todd H. Baron
Journal:  Curr Treat Options Gastroenterol       Date:  2004-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.